Catalyst Awardee

Project Description

Development and commercialization of nitric oxide therapeutic devices

Tianshu Chu, PhD | The First Hospital Affiliated of USTC, Anhui Provincial Hospital; Jianjun Ge, PhD,Chun Dai, PhD
Competition Sponsor:
 Chinese Academy of Medical Sciences
Awardee Year: 2023

Inhaled Nitric Oxide can be used to treat a variety of conditions including pulmonary hypertension and respiratory failure, however, inhaled Nitric Oxide therapy requires the use of specialized device. Inhaled nitric oxide therapy was initially applied to critically ill neonates with pulmonary hypertension who were connected to a ventilator, and was later expanded to critically ill adults, however, a large number of clinical practices and studies have found that it is also effective in patients who are not connected to a ventilator. The project team has verified the safety and effectiveness of “In heaven” technology in multi-scenario inhalation nitric oxide therapeutic device through clinical research, and developed the Oxygen Mixing Inhalation Nitric Oxide device based on the “In heaven” technology, Based on the “In heaven” technology, we have developed three medical devices: oxygen mixing inhalation nitric oxide controller, direct inhalation nitric oxide device and pulse nitric oxide device.

Sign up for updates